News & Impact Stories at Columbia SPS News at Columbia SPS Category - Any -AlumniFacultyImpacts and InsightsIn the CommunityIn the MediaKnowledge BaseOffice of the DeanPress ReleaseResearch & PublicationsSchoolStaffStudent Faculty Did “VIP Syndrome” Play a Role in Prince’s Death? Robert Klitzman writes about a surprising possible factor in the death of legendary musician Prince: VIP Syndrome. Faculty ‘The Ethics Police’ Asks Who Regulates Medical Research The Journal Inquirer explores Dr. Klitzman’s study of the ethical questions that arise in medical experimentation. Faculty Skye C. Cleary Visits the Existentialist Cafe Skye C. Cleary explains how apricot cocktails created existentialist philosophy in a new book review. Faculty Q&A With Digital Media Pioneer Sree Sreenivasan: “I Run a Startup Inside a 140-Year-Old Company” I call myself the Chief Listening Officer of The Met—someone has to be listening for what’s new, what’s working, and what’s not Faculty Top Swiss CIO Joins Technology Management Program as Mentor Technology can be harnessed as something that works for the company and its consumers, according to Ursula Soritsch-Reiner. Faculty Should You Take a Genetics Test? Business Insider chatted with Robert Klitzman about at-home genetic testing. Faculty How Business Leaders Handle Ambiguous Problems Michael Iacona advises executives to harness ambiguity (such as unclear problems) and create solutions. Faculty Health Affairs Reviews ‘The Ethics Police?’ Klitzman, the director of the Bioethics master’s program, examines the ethics of institutional review boards (IRBs). Faculty Bioethicists Discuss Gene Editing's Deadly Potential Bioethicists have weighed in on gene editing’s dark side. Faculty Talks@Columbia Season 2 Now Available This season’s Talks@Columbia features Columbia University’s Dr. Lee Goldman, Dr. Robert Klitzman, and Dr. Peter de Menocal. Faculty Technology Management Mentor Joins J.Crew as New CIO Michelle Garvey was recently hired as J.Crew’s Chief Information Officer. Faculty Robert Klitzman Talks Gene Editing on StarTalk with Neil deGrasse Tyson We may soon have the technology to edit the genes of embryos, but where does society draw the line? Load More
Faculty Did “VIP Syndrome” Play a Role in Prince’s Death? Robert Klitzman writes about a surprising possible factor in the death of legendary musician Prince: VIP Syndrome.
Faculty ‘The Ethics Police’ Asks Who Regulates Medical Research The Journal Inquirer explores Dr. Klitzman’s study of the ethical questions that arise in medical experimentation.
Faculty Skye C. Cleary Visits the Existentialist Cafe Skye C. Cleary explains how apricot cocktails created existentialist philosophy in a new book review.
Faculty Q&A With Digital Media Pioneer Sree Sreenivasan: “I Run a Startup Inside a 140-Year-Old Company” I call myself the Chief Listening Officer of The Met—someone has to be listening for what’s new, what’s working, and what’s not
Faculty Top Swiss CIO Joins Technology Management Program as Mentor Technology can be harnessed as something that works for the company and its consumers, according to Ursula Soritsch-Reiner.
Faculty Should You Take a Genetics Test? Business Insider chatted with Robert Klitzman about at-home genetic testing.
Faculty How Business Leaders Handle Ambiguous Problems Michael Iacona advises executives to harness ambiguity (such as unclear problems) and create solutions.
Faculty Health Affairs Reviews ‘The Ethics Police?’ Klitzman, the director of the Bioethics master’s program, examines the ethics of institutional review boards (IRBs).
Faculty Bioethicists Discuss Gene Editing's Deadly Potential Bioethicists have weighed in on gene editing’s dark side.
Faculty Talks@Columbia Season 2 Now Available This season’s Talks@Columbia features Columbia University’s Dr. Lee Goldman, Dr. Robert Klitzman, and Dr. Peter de Menocal.
Faculty Technology Management Mentor Joins J.Crew as New CIO Michelle Garvey was recently hired as J.Crew’s Chief Information Officer.
Faculty Robert Klitzman Talks Gene Editing on StarTalk with Neil deGrasse Tyson We may soon have the technology to edit the genes of embryos, but where does society draw the line?
